Eastman Kodak Expands Regulated Pharma Offerings, Shares Gain
Eastman Kodak Co. stock rose 4.7% Monday after the company unveiled four new regulated pharmaceutical products — two Phosphate Buffered Saline (PBS) formulations and two Water for Injection (WFI) items — all produced in a cGMP-compliant Rochester facility and immediately available to research laboratories, biopharma developers and contract developm…